SlideShare a Scribd company logo
Meningococcal Disease
By- Sumbul Parveen
Group- GM20-115
It commences suddenly with prostration of strength,
often extreme: the face is distorted, the pulse feeble.
There appears a violent pain in the head, especially
over the forehead; then there comes pain of the heart or
vomiting of greenish material, stiffness of the spine,
and in infants, convulsions. In cases which were fatal,
loss of consciousness occurred. The course of the
disease is very rapid, termination by death or by cure.
In most of the patients who died in 24 hours or a little
after, the body is covered with purple spots at the
moment of death or very little time afterward.
The Disease Which Raged During the Spring of 1805
Gaspard Vieusseux
Epidemiology
• In the United States, approximately 3000
sporadic cases occur each year.
• Nasopharyngeal carriage rate: 3-15%
• Belt across sub-Saharan Africa: 1%
• In Taiwan, 81 sporadic cases occurred from
1992 to 2000 including 8 fetal cases.
• In 2001, 30 sporadic cases occurred
including 6 fetal cases.
Microbiology
Family Neisseriaceae contains five genera:
• Neisseria
• Kingella
• Eikenella
• Simonsiella
• Alysiella.
Genus of Neisseria
• N. gonorrhoeae
• N. meningitidis
• N. kochii
• N. sicca
• N. lactamica
• N. subflava
• N. flavescens
•N. mucosa
•N. cinerea
•N. polysacchreae
•N. elongata
•N. macacae
•N. canis
•N. dentrificans.
N. meningitidis
• gram-negative diplococcus, kidney beans,
encapsulated
• facultatively anaerobic, catalase (+) and
oxidase (+)
• autolyse when exposed to drying or sunlight
• 13 serogroups currently are recognized: A,
B, C, D, H, I, K, L, X, Y, Z, W135, and 29E.
Group Chemical Composition of Capsule
A
B
C
D
X
Y
Z
29E
W135
2-Acetamido-2-deoxy-D-mannopyranosyl
phosphate
-2.8 N-acetylneuraminic acid
-2,9 O-acetylneuraminic acid
Composition not known
2-Acetamido-2-deoxy-D-glucopyranosyl phosphate
4-O--D-glucopyranosyl-N-acetylneuraminic acid
Composition not known
3-deoxy-D-manno-octulosonic acid
4-O--D-galactopyranosyl-N-acetylneuraminic acid
Chemical Structure of Group-Specific
Polysaccharide Capsules of Meningococci
• Serogroups A, B, and C account for more than 90
% of meningococcal disease worldwide.
• Serogroup A: periodic epidemics in developing
countries, is responsible for only 3 % of in the
United States.
• Serogroup B: sporadic disease but occasionally is
associated with outbreaks.
• Serogroup C: associated with numerous outbreaks
in the United States, Canada, and Europe.
• Serotype Y: has been associated with
meningococcal pneumonia in military recruits.
• The germ is spread by direct contact with
secretions from the nose and throat, such as
by kissing, coughing, sneezing, and sharing
of cigarettes, drinks, and food.
• Prevalence : winter and spring
• Incubation period: 1-10 days, most < 4
days
Risk factors
• inversely to age
• upper respiratory pathogens
• smoke and passive smoke
• family members
• late complement component deficiencies
• alternate pathway (properdin) deficiency
Clinical manifestations
• Serious/Invasive Disease
• Conjunctivitis
• Pharyngitis
• Meningococcal Pneumonia
• Meningococcal Pericarditis
• Mesenteric Adenitis and Peritonitis
• Infections of the Genitourinary Tract
• Chronic Meningococcemia
• Symptoms are usually sudden and initially
are like the flu: fever, feeling generally
unwell, headache, vomiting, and in some
cases a stiff neck.
• People with this disease are visibly sick and
may be confused, excited, or drowsy.
• Sometimes a reddish-purple rash that may
look like bruises appears.
Symptoms and Signs
• The rash is flat and smooth, does not itch,
and may spread quickly once it starts.
• In rare cases, the symptoms are followed by
lowered blood pressure, shock, delirium,
sudden extreme weakness, coma, and death.
• Because the disease spreads quickly in the
body, it is important to see a physician
immediately if symptoms suggesting
meningococcal disease develop.
Clinical Feature Per Cent at Presentation
Fever 71-88.8
Rash 68.4-71
Shock 38-42
Vomiting 34-67
Lethargy 30-55
Headache 34
Irritability 21-34
Poor feeding 18
Cough or rhinorrhea 18
Seizures 8-10
Signs and Symptoms in Serious
Meningococcal Disease
Laboratory findings
• Leukopenia <5000/ mm3 : 21 %
• Thrombocytopenia : 14 %
• Hyponatremia(SIADH): 7%
• DIC
• Acidosis
• Liver function
Diagnosis
• Culture: Gold standard
Blood culture alone is positive about 50 %
• Gram stain: Rapid diagnosis
• Counterimmunoelectrophoresis and latex
agglutination:
Cross reaction to E. coli or bacillus
• Polymerase chain reaction : newer tests
Specificity : 91 %
Case Definitions for
Invasive Meningococcal Disease
Therapy
• For penicillin-susceptible meningococcemia
or meningitis, iv penicillin G, 250,000
units/kg/day every 4 hours for 7 days.
• Third-generation cephalosporins,
ceftriaxone (100 mg/kg/day iv in two
divided doses) and cefotaxime (200 mg/
kg/day iv in four divided doses
• Steroid therapy is controversal
Presenting Features of Meningococcal
Infection Associated with Poor Prognosis
• Presence of petechiae < 12 hours before
admission
• Presence of hypotension (systolic <70 mm Hg)
• Absence of meningitis (<20 WBC/mm3)
• Peripheral white blood cell count <10,000/mm3
• Erythrocyte sedimentation rate <10 mm/hour
Stiehm, E. R.et al J. Pediatr 1966
Additional prophylactic
• Rifampin, 10 mg/ kg/dose (maximum, 600
mg/dose) every 12 hours for 2 days
• Single ceftriaxone (125 mg IM for children
< 12 years of age or 250 mg IM for those >
12 years of age)
Disease Risk for Contacts of Index Cases of
Invasive Meningococcal Disease
Drug Age Group Dose Duration
Rifampin <1 month 5 mg/kg q 12 hr 2 days
> 1 month 10 mg/kg q 12 hr 2 days
Adults 600 mg q 12 hr 2 days
Ciprofloxacin Adults 500 mg Single dose
Ceftriaxone <15 years 125 mg IM Single dose
Adults 250 mg IM Single dose
Chemoprophylaxis
Recommendations for Administration of
Meningococcal Vaccine

More Related Content

Similar to Meningococcal infection

Typhoid fever
Typhoid feverTyphoid fever
Meningococcal disease
 Meningococcal disease Meningococcal disease
Meningococcal disease
thuphan95
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
Nadia Shams
 
Exotic viral infections and the liver
Exotic viral infections and the liverExotic viral infections and the liver
Exotic viral infections and the liverMario Mondelli
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
Dr. Samira Fattah
 
Meningitis.pptx
Meningitis.pptxMeningitis.pptx
Meningitis.pptx
Dr. Adamu Ibrahim
 
Vulvovaginitis2
Vulvovaginitis2Vulvovaginitis2
Vulvovaginitis2
Israel vasquez
 
scrub typhus.pptx dr.ramjiban yadav nepal
scrub typhus.pptx dr.ramjiban yadav nepalscrub typhus.pptx dr.ramjiban yadav nepal
scrub typhus.pptx dr.ramjiban yadav nepal
RAMJIBANYADAV2
 
Infections and pregnancy
Infections and pregnancyInfections and pregnancy
Infections and pregnancy
NkosinathiManana2
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
Nadia Shams
 
Meningitis
MeningitisMeningitis
Meningitis
ChukwudiAgbor
 
Meningitis
MeningitisMeningitis
Overview of viral haemorrhagic fevers with focus on Lassa fever.pptx
Overview of viral haemorrhagic fevers with focus on Lassa fever.pptxOverview of viral haemorrhagic fevers with focus on Lassa fever.pptx
Overview of viral haemorrhagic fevers with focus on Lassa fever.pptx
ssuser6de8b3
 
Newborn infection
Newborn infectionNewborn infection
Newborn infection
Abu Takele
 
seminar Presentation covid 19 in children
seminar Presentation covid 19 in childrenseminar Presentation covid 19 in children
seminar Presentation covid 19 in children
Dr. Habibur Rahim
 
kala Azar
kala Azarkala Azar

Similar to Meningococcal infection (20)

Typhoid
TyphoidTyphoid
Typhoid
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
 
Meningococcal disease
 Meningococcal disease Meningococcal disease
Meningococcal disease
 
TORCH
TORCHTORCH
TORCH
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
 
Exotic viral infections and the liver
Exotic viral infections and the liverExotic viral infections and the liver
Exotic viral infections and the liver
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
 
Malaria new(corrected)
Malaria new(corrected)Malaria new(corrected)
Malaria new(corrected)
 
Meningitis.pptx
Meningitis.pptxMeningitis.pptx
Meningitis.pptx
 
Vulvovaginitis2
Vulvovaginitis2Vulvovaginitis2
Vulvovaginitis2
 
scrub typhus.pptx dr.ramjiban yadav nepal
scrub typhus.pptx dr.ramjiban yadav nepalscrub typhus.pptx dr.ramjiban yadav nepal
scrub typhus.pptx dr.ramjiban yadav nepal
 
Infections and pregnancy
Infections and pregnancyInfections and pregnancy
Infections and pregnancy
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
 
Meningitis
MeningitisMeningitis
Meningitis
 
Meningitis
MeningitisMeningitis
Meningitis
 
Overview of viral haemorrhagic fevers with focus on Lassa fever.pptx
Overview of viral haemorrhagic fevers with focus on Lassa fever.pptxOverview of viral haemorrhagic fevers with focus on Lassa fever.pptx
Overview of viral haemorrhagic fevers with focus on Lassa fever.pptx
 
Newborn infection
Newborn infectionNewborn infection
Newborn infection
 
seminar Presentation covid 19 in children
seminar Presentation covid 19 in childrenseminar Presentation covid 19 in children
seminar Presentation covid 19 in children
 
Neisseria meningitidis
Neisseria meningitidisNeisseria meningitidis
Neisseria meningitidis
 
kala Azar
kala Azarkala Azar
kala Azar
 

More from DeveshAhir

peritonitisgdbdbrhrhdhrhgdbfbfbfbfbfn.pptx
peritonitisgdbdbrhrhdhrhgdbfbfbfbfbfn.pptxperitonitisgdbdbrhrhdhrhgdbfbfbfbfbfn.pptx
peritonitisgdbdbrhrhdhrhgdbfbfbfbfbfn.pptx
DeveshAhir
 
Thamanna.pptxjabsbjsbsjsnsjdnnsjs hi sjkw
Thamanna.pptxjabsbjsbsjsnsjdnnsjs hi sjkwThamanna.pptxjabsbjsbsjsnsjdnnsjs hi sjkw
Thamanna.pptxjabsbjsbsjsnsjdnnsjs hi sjkw
DeveshAhir
 
T. .pptx
T.                                        .pptxT.                                        .pptx
T. .pptx
DeveshAhir
 
Rectal diseases. ..pptx
Rectal diseases.                   ..pptxRectal diseases.                   ..pptx
Rectal diseases. ..pptx
DeveshAhir
 
acute intestinal obstruction. .pptx
acute intestinal obstruction.       .pptxacute intestinal obstruction.       .pptx
acute intestinal obstruction. .pptx
DeveshAhir
 
Acute appendicitis .pptx
Acute appendicitis                  .pptxAcute appendicitis                  .pptx
Acute appendicitis .pptx
DeveshAhir
 
Peptic ulcer disease abdur rahman pptx
Peptic ulcer disease abdur rahman    pptxPeptic ulcer disease abdur rahman    pptx
Peptic ulcer disease abdur rahman pptx
DeveshAhir
 
FOREARM TRAUMA. .pptx.
FOREARM  TRAUMA.                    .pptx.FOREARM  TRAUMA.                    .pptx.
FOREARM TRAUMA. .pptx.
DeveshAhir
 
Upper Extremities injury. .pptx
Upper Extremities injury.            .pptxUpper Extremities injury.            .pptx
Upper Extremities injury. .pptx
DeveshAhir
 
Dislocations of the Upper Extremity .pptx
Dislocations of the Upper Extremity .pptxDislocations of the Upper Extremity .pptx
Dislocations of the Upper Extremity .pptx
DeveshAhir
 
Upper_limb_injuries_x_raysjBqbbsbdhns.ppt
Upper_limb_injuries_x_raysjBqbbsbdhns.pptUpper_limb_injuries_x_raysjBqbbsbdhns.ppt
Upper_limb_injuries_x_raysjBqbbsbdhns.ppt
DeveshAhir
 
acute-liver-failurekjsndhhdbdjiddjigxjdif
acute-liver-failurekjsndhhdbdjiddjigxjdifacute-liver-failurekjsndhhdbdjiddjigxjdif
acute-liver-failurekjsndhhdbdjiddjigxjdif
DeveshAhir
 
Acute GI Bleedding .ppt
Acute GI Bleedding .pptAcute GI Bleedding .ppt
Acute GI Bleedding .ppt
DeveshAhir
 
elective-neurosurgery.pptx
elective-neurosurgery.pptxelective-neurosurgery.pptx
elective-neurosurgery.pptx
DeveshAhir
 
pneumonia.pptx
pneumonia.pptxpneumonia.pptx
pneumonia.pptx
DeveshAhir
 
ovarian cancer.pptx
ovarian cancer.pptxovarian cancer.pptx
ovarian cancer.pptx
DeveshAhir
 
Ovarian Cancer[1].ppt
Ovarian Cancer[1].pptOvarian Cancer[1].ppt
Ovarian Cancer[1].ppt
DeveshAhir
 
Ovarian cancer .pptx
Ovarian cancer .pptxOvarian cancer .pptx
Ovarian cancer .pptx
DeveshAhir
 
Ovarian cancer .pptx
Ovarian cancer .pptxOvarian cancer .pptx
Ovarian cancer .pptx
DeveshAhir
 
document.pptx
document.pptxdocument.pptx
document.pptx
DeveshAhir
 

More from DeveshAhir (20)

peritonitisgdbdbrhrhdhrhgdbfbfbfbfbfn.pptx
peritonitisgdbdbrhrhdhrhgdbfbfbfbfbfn.pptxperitonitisgdbdbrhrhdhrhgdbfbfbfbfbfn.pptx
peritonitisgdbdbrhrhdhrhgdbfbfbfbfbfn.pptx
 
Thamanna.pptxjabsbjsbsjsnsjdnnsjs hi sjkw
Thamanna.pptxjabsbjsbsjsnsjdnnsjs hi sjkwThamanna.pptxjabsbjsbsjsnsjdnnsjs hi sjkw
Thamanna.pptxjabsbjsbsjsnsjdnnsjs hi sjkw
 
T. .pptx
T.                                        .pptxT.                                        .pptx
T. .pptx
 
Rectal diseases. ..pptx
Rectal diseases.                   ..pptxRectal diseases.                   ..pptx
Rectal diseases. ..pptx
 
acute intestinal obstruction. .pptx
acute intestinal obstruction.       .pptxacute intestinal obstruction.       .pptx
acute intestinal obstruction. .pptx
 
Acute appendicitis .pptx
Acute appendicitis                  .pptxAcute appendicitis                  .pptx
Acute appendicitis .pptx
 
Peptic ulcer disease abdur rahman pptx
Peptic ulcer disease abdur rahman    pptxPeptic ulcer disease abdur rahman    pptx
Peptic ulcer disease abdur rahman pptx
 
FOREARM TRAUMA. .pptx.
FOREARM  TRAUMA.                    .pptx.FOREARM  TRAUMA.                    .pptx.
FOREARM TRAUMA. .pptx.
 
Upper Extremities injury. .pptx
Upper Extremities injury.            .pptxUpper Extremities injury.            .pptx
Upper Extremities injury. .pptx
 
Dislocations of the Upper Extremity .pptx
Dislocations of the Upper Extremity .pptxDislocations of the Upper Extremity .pptx
Dislocations of the Upper Extremity .pptx
 
Upper_limb_injuries_x_raysjBqbbsbdhns.ppt
Upper_limb_injuries_x_raysjBqbbsbdhns.pptUpper_limb_injuries_x_raysjBqbbsbdhns.ppt
Upper_limb_injuries_x_raysjBqbbsbdhns.ppt
 
acute-liver-failurekjsndhhdbdjiddjigxjdif
acute-liver-failurekjsndhhdbdjiddjigxjdifacute-liver-failurekjsndhhdbdjiddjigxjdif
acute-liver-failurekjsndhhdbdjiddjigxjdif
 
Acute GI Bleedding .ppt
Acute GI Bleedding .pptAcute GI Bleedding .ppt
Acute GI Bleedding .ppt
 
elective-neurosurgery.pptx
elective-neurosurgery.pptxelective-neurosurgery.pptx
elective-neurosurgery.pptx
 
pneumonia.pptx
pneumonia.pptxpneumonia.pptx
pneumonia.pptx
 
ovarian cancer.pptx
ovarian cancer.pptxovarian cancer.pptx
ovarian cancer.pptx
 
Ovarian Cancer[1].ppt
Ovarian Cancer[1].pptOvarian Cancer[1].ppt
Ovarian Cancer[1].ppt
 
Ovarian cancer .pptx
Ovarian cancer .pptxOvarian cancer .pptx
Ovarian cancer .pptx
 
Ovarian cancer .pptx
Ovarian cancer .pptxOvarian cancer .pptx
Ovarian cancer .pptx
 
document.pptx
document.pptxdocument.pptx
document.pptx
 

Recently uploaded

CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
Nguyen Thanh Tu Collection
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
PedroFerreira53928
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 

Recently uploaded (20)

CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 

Meningococcal infection

  • 1. Meningococcal Disease By- Sumbul Parveen Group- GM20-115
  • 2. It commences suddenly with prostration of strength, often extreme: the face is distorted, the pulse feeble. There appears a violent pain in the head, especially over the forehead; then there comes pain of the heart or vomiting of greenish material, stiffness of the spine, and in infants, convulsions. In cases which were fatal, loss of consciousness occurred. The course of the disease is very rapid, termination by death or by cure. In most of the patients who died in 24 hours or a little after, the body is covered with purple spots at the moment of death or very little time afterward. The Disease Which Raged During the Spring of 1805 Gaspard Vieusseux
  • 3. Epidemiology • In the United States, approximately 3000 sporadic cases occur each year. • Nasopharyngeal carriage rate: 3-15% • Belt across sub-Saharan Africa: 1% • In Taiwan, 81 sporadic cases occurred from 1992 to 2000 including 8 fetal cases. • In 2001, 30 sporadic cases occurred including 6 fetal cases.
  • 4. Microbiology Family Neisseriaceae contains five genera: • Neisseria • Kingella • Eikenella • Simonsiella • Alysiella.
  • 5. Genus of Neisseria • N. gonorrhoeae • N. meningitidis • N. kochii • N. sicca • N. lactamica • N. subflava • N. flavescens •N. mucosa •N. cinerea •N. polysacchreae •N. elongata •N. macacae •N. canis •N. dentrificans.
  • 6. N. meningitidis • gram-negative diplococcus, kidney beans, encapsulated • facultatively anaerobic, catalase (+) and oxidase (+) • autolyse when exposed to drying or sunlight • 13 serogroups currently are recognized: A, B, C, D, H, I, K, L, X, Y, Z, W135, and 29E.
  • 7. Group Chemical Composition of Capsule A B C D X Y Z 29E W135 2-Acetamido-2-deoxy-D-mannopyranosyl phosphate -2.8 N-acetylneuraminic acid -2,9 O-acetylneuraminic acid Composition not known 2-Acetamido-2-deoxy-D-glucopyranosyl phosphate 4-O--D-glucopyranosyl-N-acetylneuraminic acid Composition not known 3-deoxy-D-manno-octulosonic acid 4-O--D-galactopyranosyl-N-acetylneuraminic acid Chemical Structure of Group-Specific Polysaccharide Capsules of Meningococci
  • 8. • Serogroups A, B, and C account for more than 90 % of meningococcal disease worldwide. • Serogroup A: periodic epidemics in developing countries, is responsible for only 3 % of in the United States. • Serogroup B: sporadic disease but occasionally is associated with outbreaks. • Serogroup C: associated with numerous outbreaks in the United States, Canada, and Europe. • Serotype Y: has been associated with meningococcal pneumonia in military recruits.
  • 9. • The germ is spread by direct contact with secretions from the nose and throat, such as by kissing, coughing, sneezing, and sharing of cigarettes, drinks, and food. • Prevalence : winter and spring • Incubation period: 1-10 days, most < 4 days
  • 10. Risk factors • inversely to age • upper respiratory pathogens • smoke and passive smoke • family members • late complement component deficiencies • alternate pathway (properdin) deficiency
  • 11. Clinical manifestations • Serious/Invasive Disease • Conjunctivitis • Pharyngitis • Meningococcal Pneumonia • Meningococcal Pericarditis • Mesenteric Adenitis and Peritonitis • Infections of the Genitourinary Tract • Chronic Meningococcemia
  • 12. • Symptoms are usually sudden and initially are like the flu: fever, feeling generally unwell, headache, vomiting, and in some cases a stiff neck. • People with this disease are visibly sick and may be confused, excited, or drowsy. • Sometimes a reddish-purple rash that may look like bruises appears. Symptoms and Signs
  • 13. • The rash is flat and smooth, does not itch, and may spread quickly once it starts. • In rare cases, the symptoms are followed by lowered blood pressure, shock, delirium, sudden extreme weakness, coma, and death. • Because the disease spreads quickly in the body, it is important to see a physician immediately if symptoms suggesting meningococcal disease develop.
  • 14. Clinical Feature Per Cent at Presentation Fever 71-88.8 Rash 68.4-71 Shock 38-42 Vomiting 34-67 Lethargy 30-55 Headache 34 Irritability 21-34 Poor feeding 18 Cough or rhinorrhea 18 Seizures 8-10 Signs and Symptoms in Serious Meningococcal Disease
  • 15. Laboratory findings • Leukopenia <5000/ mm3 : 21 % • Thrombocytopenia : 14 % • Hyponatremia(SIADH): 7% • DIC • Acidosis • Liver function
  • 16. Diagnosis • Culture: Gold standard Blood culture alone is positive about 50 % • Gram stain: Rapid diagnosis • Counterimmunoelectrophoresis and latex agglutination: Cross reaction to E. coli or bacillus • Polymerase chain reaction : newer tests Specificity : 91 %
  • 17. Case Definitions for Invasive Meningococcal Disease
  • 18. Therapy • For penicillin-susceptible meningococcemia or meningitis, iv penicillin G, 250,000 units/kg/day every 4 hours for 7 days. • Third-generation cephalosporins, ceftriaxone (100 mg/kg/day iv in two divided doses) and cefotaxime (200 mg/ kg/day iv in four divided doses • Steroid therapy is controversal
  • 19. Presenting Features of Meningococcal Infection Associated with Poor Prognosis • Presence of petechiae < 12 hours before admission • Presence of hypotension (systolic <70 mm Hg) • Absence of meningitis (<20 WBC/mm3) • Peripheral white blood cell count <10,000/mm3 • Erythrocyte sedimentation rate <10 mm/hour Stiehm, E. R.et al J. Pediatr 1966
  • 20. Additional prophylactic • Rifampin, 10 mg/ kg/dose (maximum, 600 mg/dose) every 12 hours for 2 days • Single ceftriaxone (125 mg IM for children < 12 years of age or 250 mg IM for those > 12 years of age)
  • 21. Disease Risk for Contacts of Index Cases of Invasive Meningococcal Disease
  • 22. Drug Age Group Dose Duration Rifampin <1 month 5 mg/kg q 12 hr 2 days > 1 month 10 mg/kg q 12 hr 2 days Adults 600 mg q 12 hr 2 days Ciprofloxacin Adults 500 mg Single dose Ceftriaxone <15 years 125 mg IM Single dose Adults 250 mg IM Single dose Chemoprophylaxis
  • 23. Recommendations for Administration of Meningococcal Vaccine